{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:59:28Z","timestamp":1786751968295,"version":"build-2736575974"},"reference-count":73,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2024,7,2]]},"DOI":"10.1080\/10428194.2024.2338851","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T17:16:36Z","timestamp":1713460596000},"page":"1044-1054","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Management of relapsed\/refractory mantle cell lymphoma"],"prefix":"10.1080","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0895-5114","authenticated-orcid":false,"given":"Musa","family":"Alzahrani","sequence":"first","affiliation":[{"name":"Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4625-3009","authenticated-orcid":false,"given":"Diego","family":"Villa","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada"},{"name":"Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2008.057455"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp495"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-117010"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095331"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17063"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00739-X"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000333"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1701769"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00447-7"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201817"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-163018"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_349509"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0209-5"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.03.001"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12030376"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306220"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.4471.4471"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000712"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014162"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01210"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021306"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000412"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00224-5"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00562"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-673145"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv111"},{"key":"e_1_3_3_29_1","doi-asserted-by":"crossref","unstructured":"Wang M Munoz J Goy A et al. KTE-X19 CAR T-cell therapy in relapsed or refractory mantle cell lymphoma. NEJM 2020; 382:1331\u20131342.","DOI":"10.1056\/NEJMoa1914347"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JClinOncol.21.02370"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.7507"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01797"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02214"},{"key":"e_1_3_3_34_1","unstructured":"Minson A Hamad N Cheah CY. A phase II Open-Label single arm trial to assess the efficacy and safety of the combination of tisagenleucel and ibrutinib in mantle cell lymphoma (TARMAC). Blood 2024; 143 (8): 673\u2013684."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002936"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.262"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009804"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.4320"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.198812"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005357"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008727"},{"key":"e_1_3_3_42_1","doi-asserted-by":"crossref","unstructured":"Frustaci AM Soumerai JD Lasica M et\u00a0al. A phase 1 study with the novel B-cell lymphoma 2 inhibitor sonrotoclax (BGB-11417) as monotherapy or in combination with zanubrutinib in patients with non-Hodgkin lymphoma or waldenstrom macroglobulinemia: Preliminary data. Presented at the 50th italian society of hematology national congress October 2023. Rome Italy. https:\/\/www.beigenemedical.com\/CongressDocuments\/Frustaci_BGB-11417-101_SIE_Poster_2023.pdf","DOI":"10.1182\/blood-2022-169664"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148949"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-174956"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00430-6"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000847788.96420.63"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-167153"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70128-2"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147867"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30196-0"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006555"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.4648"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2437_38"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.224535"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-886457"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.7977"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.053173"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn656"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00559-8"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13456"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2478-9"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01013-3"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14141"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.01.009"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.04.006"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00667-4"},{"key":"e_1_3_3_67_1","doi-asserted-by":"crossref","unstructured":"Wang M Rule S Zinzani PL et al. Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm multicentre phase 2 trial. The Lancet Volume 391 Issue 10121 17\u201323 February 2018 Pages 659\u2013667","DOI":"10.1016\/S0140-6736(17)33108-2"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020004074"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01174-3"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-136158"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-153277"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-165031"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006922"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715519"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2024.2338851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T22:51:40Z","timestamp":1727218300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2024.2338851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,7,2]]}},"alternative-id":["10.1080\/10428194.2024.2338851"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2024.2338851","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}